SCCM
Schafer Cullen Capital Management Portfolio holdings
AUM
$491M
This Quarter Return
+2.36%
1 Year Return
+41.48%
3 Year Return
+28.47%
5 Year Return
+53.25%
10 Year Return
–
AUM
$8.04B
AUM Growth
+$8.04B
(+3.2%)
Cap. Flow
+$6.98M
Cap. Flow
% of AUM
0.09%
Top 10 Holdings %
Top 10 Hldgs %
22.29%
Holding
290
New
11
Increased
104
Reduced
120
Closed
11
Top Buys
| 1 |
Novartis
NVS
|
$19.5M |
| 2 |
Exxon Mobil
XOM
|
$18.5M |
| 3 |
Johnson Controls International
JCI
|
$16.3M |
| 4 |
Archer Daniels Midland
ADM
|
$14.6M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
$10.7M |
Top Sells
| 1 |
Philip Morris
PM
|
$39.3M |
| 2 |
UN
Unilever NV New York Registry Shares
UN
|
$29.3M |
| 3 |
CEO
CNOOC Limited
CEO
|
$27.2M |
| 4 |
3M
MMM
|
$25.2M |
| 5 |
GSK
GSK
|
$13.3M |
Sector Composition
| 1 | Financials | 15.65% |
| 2 | Healthcare | 12.88% |
| 3 | Industrials | 9.39% |
| 4 | Technology | 8.75% |
| 5 | Energy | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Novartis
NVS
$245B
| $232M | 2.89% | 2,780,606 +233,292 | +9% | +$19.5M |
|
|
UN
2
DELISTED
Unilever NV New York Registry Shares
UN
| $218M | 2.72% | 3,949,452 -529,421 | -12% | -$29.3M |
|
3
HSBC
HSBC
$224B
| $184M | 2.29% | 3,965,193 +82,066 | +2% | +$3.81M |
|
|
RDS.B
4
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $176M | 2.19% | 3,229,630 +196,151 | +6% | +$10.7M |
|
5
JPMorgan Chase
JPM
$829B
| $171M | 2.13% | 1,872,480 -85,369 | -4% | -$7.8M |
|
6
BCE
BCE
$23.3B
| $169M | 2.11% | 3,760,055 +209,395 | +6% | +$9.43M |
|
7
Johnson & Johnson
JNJ
$427B
| $168M | 2.1% | 1,273,652 -20,101 | -2% | -$2.66M |
|
8
Chubb
CB
$110B
| $161M | 2.01% | 1,110,238 -29,649 | -3% | -$4.31M |
|
9
Welltower
WELL
$113B
| $157M | 1.95% | 2,095,543 -35,330 | -2% | -$2.64M |
|
10
Cisco
CSCO
$274B
| $154M | 1.91% | 4,913,113 +59,135 | +1% | +$1.85M |
|
11
Microsoft
MSFT
$3.77T
| $152M | 1.89% | 2,199,334 -92,175 | -4% | -$6.35M |
|
12
Altria Group
MO
$113B
| $151M | 1.88% | 2,030,191 -136,012 | -6% | -$10.1M |
|
13
Diageo
DEO
$62.1B
| $148M | 1.84% | 1,235,808 -20,459 | -2% | -$2.45M |
|
14
AstraZeneca
AZN
$248B
| $144M | 1.79% | 4,212,264 +10,002 | +0.2% | +$341K |
|
15
Boeing
BA
$177B
| $144M | 1.79% | 725,815 -41,315 | -5% | -$8.17M |
|
16
Chevron
CVX
$324B
| $143M | 1.78% | 1,367,999 +83,246 | +6% | +$8.69M |
|
|
DD
17
DELISTED
Du Pont De Nemours E I
DD
| $141M | 1.75% | 1,741,586 -31,260 | -2% | -$2.52M |
|
18
Merck
MRK
$210B
| $140M | 1.74% | 2,181,647 -60,998 | -3% | -$3.91M |
|
19
AT&T
T
$209B
| $139M | 1.73% | 3,693,591 +49,837 | +1% | +$1.88M |
|
20
Wells Fargo
WFC
$263B
| $137M | 1.71% | 2,480,541 +57,401 | +2% | +$3.18M |
|
21
NextEra Energy, Inc.
NEE
$148B
| $131M | 1.63% | 934,021 -52,829 | -5% | -$7.4M |
|
22
Travelers Companies
TRV
$61.1B
| $130M | 1.62% | 1,028,604 -13,048 | -1% | -$1.65M |
|
23
GE Aerospace
GE
$292B
| $130M | 1.61% | 4,801,305 +127,570 | +3% | +$3.45M |
|
24
MetLife
MET
$54.1B
| $122M | 1.51% | 2,212,401 +132,050 | +6% | +$7.25M |
|
25
Pfizer
PFE
$141B
| $116M | 1.44% | 3,455,226 -65,053 | -2% | -$2.19M |
|